grofit: Fitting Biological Growth Curves with R
Matthias Kahm,
Guido Hasenbrink,
Hella Lichtenberg-Fraté,
Jost Ludwig and
Maik Kschischo
Journal of Statistical Software, 2010, vol. 033, issue i07
Abstract:
The grofit package was developed to fit many growth curves obtained under different conditions in order to derive a conclusive dose-response curve, for instance for a compound that potentially affects growth. grofit fits data to different parametric models and in addition provides a model free spline method to circumvent systematic errors that might occur within application of parametric methods. This amendment increases the reliability of the characteristic parameters (e.g.,lag phase, maximal growth rate, stationary phase) derived from a single growth curve. By relating obtained parameters to the respective condition (e.g.,concentration of a compound) a dose response curve can be derived that enables the calculation of descriptive pharma-/toxicological values like half maximum effective concentration (EC50). Bootstrap and cross-validation techniques are used for estimating confidence intervals of all derived parameters.
Date: 2010-02-17
References: View complete reference list from CitEc
Citations: View citations in EconPapers (9)
Downloads: (external link)
https://www.jstatsoft.org/index.php/jss/article/view/v033i07/v33i07.pdf
https://www.jstatsoft.org/index.php/jss/article/do ... 07/grofit_1.0.tar.gz
https://www.jstatsoft.org/index.php/jss/article/do ... ile/v033i07/v33i07.R
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:jss:jstsof:v:033:i07
DOI: 10.18637/jss.v033.i07
Access Statistics for this article
Journal of Statistical Software is currently edited by Bettina Grün, Edzer Pebesma and Achim Zeileis
More articles in Journal of Statistical Software from Foundation for Open Access Statistics
Bibliographic data for series maintained by Christopher F. Baum ().